Reference
Vinti L, et al. Brentuximab in Children, Adolescent and Young Adults with Relapsed/Refractory Anaplastic Large Cell Lymphoma. Blood 140 (Suppl. 1): 12141-12142, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-170118 [abstract]
Rights and permissions
About this article
Cite this article
Brentuximab vedotin. Reactions Weekly 1988, 36 (2023). https://doi.org/10.1007/s40278-023-52014-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-52014-y